Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 116866
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.116866
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.116866
Table 1 Demographic and laboratory characteristics of studied populations, mean ± SD (range)/n (%)/median (interquartile range)
| Variables | Cases (n = 79) | Controls (n = 79) | P value (F1)1 |
| Age | 49.92 ± 17.23 (20-80) | 45.92 ± 16.42 (20-88) | 0.140 |
| Gender | 0.737 | ||
| Male | 53 (67.1) | 51 (64.6) | |
| Female | 26 (32.9) | 28 (35.4) | |
| Blood picture | |||
| White blood cells | 5 (2.0-10.0) | 5 (2.4-10.0) | 0.083 |
| Hemoglobin | 12.13 ± 1.77 (8.0-16.0) | 12.90 ± 2.01 (6.5-17.0) | 0.012 |
| Platelets | 191.00 (34-519) | 275.00 (68-815) | < 0.001 |
| Kidney functions | |||
| Blood urea | 4.51 ± 1.43 (2.0-10.0) | 4.60 ± 1.21 (2.6-9.0) | 0.702 |
| Serum creatinine | 72.87 ± 26.48 (30-181) | 72.51 ± 17.27 (30-120) | 0.919 |
| eGFR | 103.92 ± 29.23 (32-175) | 101.78 ± 21.80 (55-151) | 0.605 |
| Urinary alpha-one-microglobulin | 4.11 ± 1.52 (2.11-9.18) | 2.54 ± 0.78 (0.77-3.97) | < 0.001 |
| Liver function tests | |||
| Total bilirubin | 8.00 (3.0-136.0) | 7.00 (1.0-19.0) | 0.141 |
| Direct bilirubin | 5.50 (0.9-96.0) | 4.00 (1.0-13.0) | < 0.001 |
| Aspartate aminotransferase | 40.00 (12-124) | 26.00 (10-87) | < 0.001 |
| Alanine aminotransferase | 38.00 (10-130) | 26.00 (7-130) | < 0.001 |
| Alkaline phosphatase | 67.00 (40-466) | 55.00 (38-90) | < 0.001 |
| Albumin | 33.90 ± 7.17 (13.0-49.0) | 36.87 ± 4.19 (28.0-46.0) | 0.002 |
| Coagulation profile | |||
| Prothrombin concentration | < 0.001 | ||
| Normal | 54 (70.1) | 79 (100.0) | |
| Impaired | 23 (29.9) | 0 (0.0) | |
| INR | < 0.001 | ||
| Normal | 54 (70.1) | 79 (100.0) | |
| Impaired | 23 (29.9) | 0 (0.0) | |
| Blood glucose | 0.999 | ||
| Normal | 78 (98.7) | 79 (100.0) | |
| High | 1 (1.3) | 0 (0.0) | |
| Hemoglobin A1C | 0.999 | ||
| Normal | 78 (98.7) | 79 (100.0) | |
| Abnormal | 1 (1.3) | 0 (0.0) |
Table 2 Correlation between Urinary alpha one microglobulin and other variables among studied patients with hepatitis C virus
| Variables | Urinary alpha one microglobulin | |
| r | P value | |
| Age | -0.122 | 0.291 |
| Kidney functions | ||
| Blood urea nitrogen | 0.456 | < 0.001 |
| Serum creatinine | 0.355 | 0.003 |
| Estimated glomerular filtration rate | -0.267 | 0.017 |
| Urine albumin/creatinine ratio | 0.050 | 0.659 |
| Liver function tests | ||
| Total bilirubin | -0.050 | 0.664 |
| Direct bilirubin | -0.023 | 0.843 |
| Aspartate aminotransferase | -0.233 | 0.039 |
| Alanine aminotransferase | -0.256 | 0.023 |
| Alkaline phosphatase | -0.113 | 0.320 |
| Albumin | -0.209 | 0.065 |
| Polymerase chain reaction value | 0.228 | 0.152 |
| Blood picture | ||
| White blood cells | 0.146 | 0.206 |
| Hemoglobin | -0.022 | 0.847 |
| Platelets | 0.071 | 0.538 |
Table 3 Difference in urinary alpha-one-microglobulin according to renal injury among patients with hepatitis C virus, mean ± SD (range)
| Variables | Urinary alpha one microglobulin (n = 79) | P value |
| Hematuria | 0.007 | |
| Normal | 3.76 ± 1.34 (2.11-9.02) | |
| Hematuria | 4.71 ± 1.67 (2.50-9.18) | |
| Proteinuria | 0.311 | |
| Normal | 3.67 ± 1.06 (2.34-5.33) | |
| Proteinuria | 4.18 ± 1.59 (2.11-9.18) | |
| Estimated glomerular filtration rate | < 0.001 | |
| < 60 (impaired) | 6.35 ± 2.54 (2.74-9.18) | |
| ≥ 60 | 3.89 ± 1.22 (2.11-7.00) | |
| Renal injury | 0.235 | |
| Yes | 4.17 ± 1.56(2.11-9.18) | |
| No | 3.45 ± 1.01 (2.34-5.00) |
Table 4 Characteristics of hepatitis c virus-positive patients groups based on presence or absence of a renal biopsy, mean ± SD (range)/n (%)/median (interquartile range)
| Variables | Patients with renal biopsy (n = 5) | Patients without renal biopsy (n = 74) |
| Age | 38.80 ± 14.85 (26-59) | 50.80 ± 16.987 (20-80) |
| Sex | ||
| Male | 2 (40.0) | 23 (31.1) |
| Female | 3 (60.0) | 51 (68.9) |
| Kidney functions | ||
| Blood urea nitrogen | 7.60 ± 2.51 (4.0-10.0) | 4.3 ± 1.7 (2-10) |
| Serum creatinine | 125.80 ± 42.72 (67-181) | 75.8 ± 26.9 (43-146) |
| Estimated glomerular filtration rate (mL/minute/1.73 m2) | 58.20 ± 26.65 (32-100) | 106.32 ± 27.017 (44-175) |
| < 60 (impaired) | 3 (60.0) | 4 (5.4) |
| ≥ 60 | 2 (40.0) | 70 (94.6) |
| Urine albumin-to-creatinine ratio | 2300.00 (1500.0-3500.0) | 553.23 (13.40-1131.8) |
| Macroalbuminuria | 5 (100.0) | 34 (45.9) |
| Hematuria | 5 (100.0) | 39 (52.7) |
| C3/C4 | ||
| Normal | 2 (40.0) | 68 (91.9) |
| Abnormal | 3 (60.0) | 6 (8.1) |
| PCR for HCV | ||
| Detectable | 0 (0) | 41 (55.4) |
| Below detection limit | 5 (100.0) | 33 (44.6) |
| Uα1M | 6.12 ± 2.36 (4.33-9.187) | 3.976 ± 1.383 (2.116-9.022) |
Table 5 Diagnostic ability of Urinary alpha-one-microglobulin to differentiate between patients with hepatitis C virus and controls
| Indices | Urinary alpha-one-microglobulin |
| AUC (95%CI) | 0.864 (0.801-0.913) |
| Optimal cut off | > 3.52 mg/L |
| Accuracy | 77.0% |
| Sensitivity | 60.0% |
| Specificity | 93.7% |
| Positive predictive value | 90.4% |
| Negative predictive value | 69.8% |
| P value | < 0.001 |
- Citation: Alkareemy EAR, Azoz NM, Abdelnaiem GS, Gadelkareem RA, Saleh KA, Abdel Aziz EM. Alpha-1-microglobulin as an early biomarker in renal extrahepatic manifestations of hepatitis C virus infection. World J Nephrol 2026; 15(2): 116866
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/116866.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.116866